All applied concentrations of IKK-16 significantly reduced the RelA/PTPIP51 interaction (0.5 μM p < 0.01; 5 μM p < 0.05) in the breast cancer cell line SKBR3. The gene discussed is RMDN3; the disease is breast carcinoma.